Answers are grounded in this paper and cite their sources.
Evaluates enhanced T-cell recruitment and ICAM expression in mice treated with ultrasound and microbubbles, indicating potential for improved therapies.
Focused ultrasound with microbubbles (FUS+MB) transiently disrupts the blood–brain barrier (BBB), alters protein expression, and recruits immune cells. Intracellular adhesion molecule (ICAM) is an important marker for leukocyte adhesion and extravasation and may play an important role in T-cell recruitment across the BBB. This study evaluates kinetic changes in ICAM expression following FUS+MB to inform combination strategies with T-cell therapies. Image-guided FUS+MB (1 MHz, 467 kPa derated, 1% duty cycle, 10 s/spot) was administered to the left hemisphere of healthy male C57Bl/6 mice. Mice (n = 3/group) were perfused and brains harvested at 0, 6, 24, and 48 h post-treatment. Frozen sections (40 μm) were stained for ICAM, astrocytes, microglia, and CD3+ T cells. QuPath analysis quantified ICAM area density and CD3+ cell density in the treated versus untreated control hemispheres. ICAM density was significantly higher in treated hemispheres compared at all timepoints (0 h: p < 0.05; 6–48 h: p < 0.0001), peaking at 24 h with 12% tissue coverage and a 4.3-fold increase over control. CD3+ cell density was also significantly elevated in treated hemispheres (0, 6 h: p < 0.0001; 24, 48 h: p < 0.001), with the highest mean density observed at 24 h (274 cells/mm2). These findings show that FUS+MB enhances ICAM expression and T-cell recruitment at the treatment site, supporting its use to improve delivery of systemically administered T-cell therapies. Future work will assess these kinetics in a murine glioma model.
No takes yet. Share an insight, caveat, or question.
VanTreeck et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: